Best Weight Loss Programs in 2026 — Ranked & Reviewed

A structured weight-loss program is not a telehealth GLP-1 prescriber, not a supplement, and not a meal-delivery service. It sits where those meet. Every program on the register is ranked below, along with an account of the categories that exist, of what the published evidence supports, and of how often programs are now paired with FDA-approved weight-loss medications in 2026.

Lowest verified price: $149/mo6 providers compared

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

6 weight loss programs compared · independently scored against our six-factor methodology.

Rankings updated August 2026

Quick Picks: Top 5

#ProviderScore
1Red Mountain Weight LossVisit
2Hone HealthVisit
3System LabsVisit
4MD Total WellnessVisit
5Kairos Aesthetic and Longevity MedicineVisit

Compare the top providers at a glance

Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.

  • ★ Editor's Pick

    compounded semaglutide at $149/month

    From /mo
    $149
    Coverage
    4 states
    Medications
    SemaglutideTirzepatide
  • Best Budget

    compounded liraglutide at $160/month

    From /mo
    $60
    Coverage
    Check intake
    Medications
    Liraglutide
  • seeing what it charges before you answer any medical questions

    From /mo
    Check pricing
    Coverage
    Check intake
    Medications
  • a published state list — 1 of 50 — when most of the register publishes none

    From /mo
    Check pricing
    Coverage
    1 states
    Medications
  • a published state list — 1 of 50 — when most of the register publishes none

    From /mo
    Check pricing
    Coverage
    1 states
    Medications
  • oral orforglipron alongside the injectables

    From /mo
    $149
    Scales with dose
    Coverage
    Check intake
    Medications
    Orforglipron
6weighted dimensions
6weight loss programs in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →

Detailed Reviews

1

Red Mountain Weight Loss

Best for: compounded semaglutide at $149/month

7.4

Programs are tiered from $199 to $599, compounded GLP-1 opens at $149/month, and the first consultation costs $55. The practice dates to 1995 and works from nine clinics in Arizona and Texas while offering telemedicine into four states. Thirty years of history, credentialing through the American Board of Obesity Medicine and physicians named on the page set it apart from a telehealth startup.

Score Breakdown

Value25%
6.7
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
8.5
Accessibility10%
2.6
Support10%
5

Pros

  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • No FDA warning letter matched this operator when we searched our enforcement register

Cons

  • Tirzepatide at $599 a month, 124% above the $267 register median for the same drug and form
  • Coverage is published for 4 states only, so this may not reach you
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
2

Hone Health

Best for: compounded liraglutide at $160/month

5.9

Hone Health is a comprehensive longevity telehealth platform for men and women, covering hormone optimization, weight management, sexual health, and metabolic health. Its weight loss formulary is compounded liraglutide at $160/mo, naltrexone at $60/mo, bupropion at $60/mo, phentermine at $65/mo, topiramate at $65/mo, and sermorelin at $130/mo. All of them require a membership, either $25/mo Basic or $149/mo Premium.

Score Breakdown

Value25%
5
Effectiveness25%
6.5
User Experience15%
7
Trust & Safety15%
6.5
Accessibility10%
5
Support10%
5

Pros

  • Liraglutide at $160 a month
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • No FDA warning letter matched this operator when we searched our enforcement register
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
  • Baseline bloodwork is required before a prescription

Cons

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its liraglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
3

System Labs

Best for: seeing what it charges before you answer any medical questions

5.2

The catalog here is peptides and longevity: NAD+, glutathione, sermorelin and a lipotropic MIC+B12 injection, all filled by compounding pharmacies licensed in the US. Neither semaglutide nor tirzepatide appears on the public list. Of what is sold, MIC+B12 is the item adjacent to weight loss, at $89/month, while NAD+ and glutathione each run $149/month, and most carry intro pricing. System Laboratories, Inc. holds LegitScript verification and states HIPAA compliance.

Score Breakdown

Value25%
3
Effectiveness25%
5
User Experience15%
8
Trust & Safety15%
6.5
Accessibility10%
5
Support10%
5

Pros

  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • No FDA warning letter matched this operator when we searched our enforcement register

Cons

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
4

MD Total Wellness

Best for: a published state list — 1 of 50 — when most of the register publishes none

4.2

MD Total Wellness is a wellness clinic in Brea, CA. It offers semaglutide next to hormone therapy, skin rejuvenation and pelvic floor treatments. The operation is a local clinic with telehealth capabilities.

Score Breakdown

Value25%
3
Effectiveness25%
5
User Experience15%
5
Trust & Safety15%
5
Accessibility10%
2.2
Support10%
5

Pros

  • No FDA warning letter matched this operator when we searched our enforcement register

Cons

  • Coverage is published for 1 states only, so this may not reach you
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
5

Kairos Aesthetic and Longevity Medicine

Best for: a published state list — 1 of 50 — when most of the register publishes none

4.1

No GLP-1 drug is named and no price is given, and none of it happens remotely. Kairos is a med-spa in Las Colinas, Irving, TX, physician-led, seen in person by appointment. Botox, fillers, lasers and facials are the aesthetics side; the wellness arm runs medical weight loss off metabolic assessment plus lab and biological-age testing, with peptides and hormone therapy attached. Weight care is built per patient and medications may form part of it. Treat this as a local Texas clinic rather than a nationwide GLP-1 service.

Score Breakdown

Value25%
3
Effectiveness25%
5
User Experience15%
5
Trust & Safety15%
4
Accessibility10%
2.2
Support10%
5

Pros

  • No FDA warning letter matched this operator when we searched our enforcement register

Cons

  • Coverage is published for 1 states only, so this may not reach you
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
How we rank, and what counts as “legit”

Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.

Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].

How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

What a weight-loss program means in 2026

Take a structured, multi-component intervention that combines at least two of these: dietary guidance, behavioral coaching, physical-activity programming, and increasingly a layer of clinical oversight extending to FDA-approved weight-loss medications. That is what qualifies in 2026. We keep programs separate from FDA-approved medications, weight-loss supplements, meal-delivery services, and pure telehealth GLP-1 prescribers — even though plenty of modern programs borrow from several at once. Where each option sits is set out in the categories below.

The four categories of structured weight-loss programs

1. Behavioral coaching programs

Examples: WeightWatchers (now WW & ZP), Noom, Found, Calibrate. Lifestyle and behavior change is the primary intervention; some now layer in GLP-1 prescribing as a Pro tier. The Diabetes Prevention Program (DPP) is the canonical NIH-published evidence base for structured behavioral weight-loss programs in adults at risk for type 2 diabetes.

2. Meal-replacement programs

Examples: Optavia, Nutrisystem, Jenny Craig, SlimFast. Some or all of the day’s food is replaced with pre-portioned meals, usually high-protein and calorie-controlled. Published trials show this works for short-term weight loss. Holding the result once the meal plan ends still takes sustained behavioral change.

3. App-based / digital health

Examples: Lose It!, MyFitnessPal Premium, Cronometer, Lifesum. Tracking of calories, macros and habits is self-directed here, with coaching optional. Cheapest category of the four, and also the one with the weakest published efficacy signal for sustained weight loss where nothing else is added.

4. GLP-1-paired hybrid programs

Examples: Hone Health, MD Total Wellness, Found (with Rx), Calibrate, the new WeightWatchers Clinic. Bundle clinical GLP-1 prescribing (semaglutide or tirzepatide, brand or compounded) with behavioral coaching, lab work, and structured follow-up. The fastest-growing category in 2026 and where most new entrants are positioning.

How programs and FDA-approved medications fit together in 2026

One condition runs through all the Phase 3 evidence published on FDA-approved weight-loss medications. Wegovy in STEP-1 and Zepbound in SURMOUNT-1, both summarized in our FDA-approved weight-loss medications hub , produced their results alongside increased physical activity and a structured reduced-calorie diet, never on their own. Prior-authorization criteria follow the same logic: Cigna and Aetna each want documented dietary and behavioral modification, 3 months for Cigna and 6 months for Aetna, BEFORE any GLP-1 is approved for weight management. Satisfying that documentation requirement is easiest to defend with a well-structured program behind it.

None of that makes a program without an FDA-approved-medication component useless. Meaningful weight loss on a behavioral or meal-replacement program alone is common, and it matters most to patients whose insurance will not cover GLP-1s. Where the patient's BMI is ≥30, or ≥27 alongside a comorbidity, and sustained loss beyond ~5-10% of body weight is the aim, published evidence increasingly points toward pairing program and medication rather than relying on either by itself.

What to check before picking a program

  • Clinical oversight where medication is involved. Confirm the prescribers are state-licensed and that a pharmacy partnership is published. Our semaglutide providers ranking and tirzepatide providers ranking record the clinical infrastructure standing behind each GLP-1-paired program.
  • How cancellation and refunds work. Traps around auto-renewal are common in this category. A cancel flow should be published, documented and easy to find.
  • What a month costs in total. A headline price is easily obscured by bundling a program fee with a medication fee and a lab fee. Our live pricing index carries the all-in monthly figure for every provider.
  • Trust signals from the provider. Look for LegitScript accreditation, a PCAB pharmacy partner, state-licensed clinicians, and an ownership and legal entity that is disclosed. Our six-factor methodology evaluates every one of those explicitly.
  • Whether insurance can be used at all. Cash-pay only is common, and that means no copay savings card, no PA letter and no Part D coverage. See our insurance coverage guide for the breakdown insurer by insurer.

Frequently Asked Questions

Sources & methodology — as of August 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)Internal Revenue Service.